The present invention relates to a compound of formula (I): or a pharmaceutical acid addition salt thereof; which is useful for activating 5-HT1F receptors and inhibiting neuronal protein extravasation in a mammal.
5-HT1F agonists
申请人:Eli Lilly and Company
公开号:US06358972B1
公开(公告)日:2002-03-19
The present invention relates to a compound of formula (I): or a pharmaceutical acid addition salt thereof; which is useful for activating 5-HT1f receptors and inhibiting protein extravasation in a mammal.